Back

Preliminary results of studying the prevalence of atrial fibrillation and the adequacy of prevention of thromboembolic complications

26 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Risk factors and screening for atrial fibrillation Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Nodir U Zakirov

Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent (Uzbekistan)

6 More presentations in this session

Presentation thumbnail
Sleep apnea independently predicts incident atrial fibrillation in the young - Implications for targeted screening
Doctor N. Bhatia (Atlanta, US)
Abstract Slides
Presentation thumbnail
Pesticide exposure an unforseen trigger for atrial fibrillation
Mr P. Kishore (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Prevalence of atrial fibrillation in patients with atrial septal defect and its impact on in-hospital outcomes
Doctor K. Htwe (Flint, US)
Abstract Slides
Presentation thumbnail
Relationship between corrected QT prolongation and new-onset atrial fibrillation in the general Japanese population
Doctor Y. Ninomiya (Kagoshima, JP)
Abstract Slides Video
Presentation thumbnail
Long-term recurrence of new-onset post-operative AF in cardiac surgery patients as detected by an implantable loop recorder: a systematic review and individual participant data meta-analysis
Miss H. Kaur (Hamilton, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and screening for atrial fibrillation

The Event

Event poster

ESC Congress 2023

26 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Session
2024 ESC Guidelines for the Management of Atrial Fibrillation
1 September 2024
thumbnail
Congress Presentation
10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation
26 August 2023
thumbnail
Congress Presentation
Prevalence of subclinical atheromatosis in low-intermediate cardiovascular risk patients with atrial fibrillation
31 August 2025
thumbnail
Congress Presentation
Who missed out on anticoagulation? a nationwide temporal analysis of patients with new-onset atrial fibrillation and no anticoagulation
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources